Applications of photodynamic therapy in keratitis.
Infection
Keratitis
Photodynamic therapy
Journal
International ophthalmology
ISSN: 1573-2630
Titre abrégé: Int Ophthalmol
Pays: Netherlands
ID NLM: 7904294
Informations de publication
Date de publication:
15 Mar 2024
15 Mar 2024
Historique:
received:
26
10
2023
accepted:
16
02
2024
medline:
18
3
2024
pubmed:
16
3
2024
entrez:
16
3
2024
Statut:
epublish
Résumé
Keratitis is corneal inflammatory disease which may be caused by several reason such as an injury, allergy, as well as a microbial infection. Besides these, overexposure to ultraviolet light and unhygienic practice of contact lenses are also associated with keratitis. Based on the cause of keratitis, different lines of treatments are recommended. Photodynamic therapy is a promising approach that utilizes light activated compounds to instigate either killing or healing mechanism to treat various diseases including both communicable and non-communicable diseases. This review focuses on clinically-important patent applications and the recent literature for the use of photodynamic therapy against keratitis.
Identifiants
pubmed: 38491335
doi: 10.1007/s10792-024-03062-4
pii: 10.1007/s10792-024-03062-4
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
140Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Nature B.V.
Références
Cope JR, Collier SA, Rao MM, Chalmers R, Mitchell GL, Richdale K, Wagner H, Kinoshita BT, Lam DY, Sorbara L, Zimmerman A (2015) Contact lens wearer demographics and risk behaviors for contact lens-related eye infections—United States, 2014. Morb Mortal Wkly Rep 64(32):865
doi: 10.15585/mmwr.mm6432a2
Keay L, Edwards K, Stapleton F (2009) Signs, symptoms, and comorbidities in contact lens-related microbial keratitis. Optom Vis Sci 86(7):803–809
doi: 10.1097/OPX.0b013e3181ae1b69
pubmed: 19543137
Singh P, Gupta A, Tripathy K (2022) Keratitis. StatPearls Publishing, St. Petersburg
Lakhundi S, Siddiqui R, Khan NA (2017) Pathogenesis of microbial keratitis. Microb Pathog 104:97–109
doi: 10.1016/j.micpath.2016.12.013
pubmed: 27998732
Randag AC, de Kroon L, Otten H, Arias Claro-Handgraaf C, Schimmer B, Kortbeek T, van Rooij J, Stelma FF (2023) In vitro effectiveness of soft contact lens solutions available on the Dutch market against Acanthamoeba species. Pathogens 12(2):214
doi: 10.3390/pathogens12020214
pubmed: 36839486
pmcid: 9959425
Siddiqui R, Lakhundi S, Khan NA (2015) Status of the effectiveness of contact lens solutions against keratitis-causing pathogens. Cont Lens Anterior Eye 38(1):34–38
doi: 10.1016/j.clae.2014.09.001
pubmed: 25280981
Tjia KF, van Putten JP, Pels E, Zanen HC (1988) The interaction between Neisseria gonorrhoeae and the human cornea in organ culture. An electron microscopic study. Graefes Arch Clin Exp Ophthalmol 226(4):341–345
doi: 10.1007/BF02172964
pubmed: 3139497
Hof H (2017) Listeria infections of the eye. Eur J Ophthalmol 27(2):115–121
doi: 10.5301/ejo.5000884
pubmed: 27791252
Chatterjee S, Agrawal D (2016) Multi-drug resistant Pseudomonas aeruginosa keratitis and its effective treatment with topical colistimethate. Ind J Ophthalmol 64(2):153–157
doi: 10.4103/0301-4738.179721
Didier ES, Maddry JA, Brindley PJ, Stovall ME, Didier PJ (2005) Therapeutic strategies for human microsporidia infections. Expert Rev Anti Infect Ther 3(3):419–434
doi: 10.1586/14787210.3.3.419
pubmed: 15954858
Wilhelmus KR (2015) Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis. Cochrane Database Syst Rev 1:CD002898
pubmed: 25879115
Khan NA, Anwar A, Siddiqui R (2019) Acanthamoeba keratitis: current status and urgent research priorities. Curr Med Chem 26(30):5711–5726
doi: 10.2174/0929867325666180510125633
pubmed: 29745319
Green MD, Apel AJ, Naduvilath T, Stapleton FJ (2007) Clinical outcomes of keratitis. Clin Exp Ophthalmol 35(5):421–426
doi: 10.1111/j.1442-9071.2007.01511.x
pubmed: 17651246
Austin A, Lietman T, Rose-Nussbaumer J (2017) Update on the management of infectious keratitis. Ophthalmology 124(11):1678–1689
doi: 10.1016/j.ophtha.2017.05.012
pubmed: 28942073
Tuft S, Somerville TF, Li JPO, Neal T, De S, Horsburgh MJ, Fothergill JL, Foulkes D, Kaye S (2022) Bacterial keratitis: identifying the areas of clinical uncertainty. Prog Retin Eye Res 89:101031
doi: 10.1016/j.preteyeres.2021.101031
pubmed: 34915112
Daniell MD, Hill JS (1991) A history of photodynamic therapy. Aust N Z J Surg 61(5):340–348
doi: 10.1111/j.1445-2197.1991.tb00230.x
pubmed: 2025186
Dolmans DE, Fukumura D, Jain RK (2003) Photodynamic therapy for cancer. Nat Rev Cancer 3(5):380–387
doi: 10.1038/nrc1071
pubmed: 12724736
Correia JH, Rodrigues JA, Pimenta S, Dong T, Yang Z (2021) Photodynamic therapy review: principles, photosensitizers, applications, and future directions. Pharmaceutics 13(9):1332
doi: 10.3390/pharmaceutics13091332
pubmed: 34575408
pmcid: 8470722
Gunaydin G, Gedik ME, Ayan S (2021) Photodynamic therapy—current limitations and novel approaches. Front Chem 9:691697
doi: 10.3389/fchem.2021.691697
pubmed: 34178948
pmcid: 8223074
Nwogu C, Kloc A, Attwood K, Bshara W, Durrani F, Pandey R (2021) Porfimer sodium versus PS785 for photodynamic therapy (PDT) of lung cancer xenografts in mice. J Surg Res 263:245–250
doi: 10.1016/j.jss.2020.12.067
pubmed: 33713956
Kim M, Jung HY, Park HJ (2015) Topical PDT in the treatment of benign skin diseases: principles and new applications. Int J Mol Sci 16(10):23259–23278
doi: 10.3390/ijms161023259
pubmed: 26404243
pmcid: 4632697
Pariser DM, Lowe NJ, Stewart DM, Jarratt MT, Lucky AW, Pariser RJ, Yamauchi PS (2003) Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J Am Acad Dermatol 48(2):227–232
doi: 10.1067/mjd.2003.49
pubmed: 12582393
Akram Z, Al-Shareef SA, Daood U, Asiri FY, Shah AH, AlQahtani MA, Vohra F, Javed F (2016) Bactericidal efficacy of photodynamic therapy against periodontal pathogens in periodontal disease: a systematic review. Photomed Laser Surg 34(4):137–149
doi: 10.1089/pho.2015.4076
pubmed: 26982216
Hung JH, Lee CN, Hsu HW, Ng IS, Wu CJ, Yu CK, Lee NY, Chang Y, Wong TW (2021) Recent advances in photodynamic therapy against fungal keratitis. Pharmaceutics 13(12):2011
doi: 10.3390/pharmaceutics13122011
pubmed: 34959293
pmcid: 8709008
de Paiva AD, da Costa Ferreira M, da Fonseca AD (2022) Photodynamic therapy for treatment of bacterial keratitis. Photodiagnosis Photodyn Ther 37:102717
doi: 10.1016/j.pdpdt.2022.102717
pubmed: 35021106
Szentmáry N, Goebels S, Bischoff M, Seitz B (2012) Photodynamic therapy for infectious keratitis. Ophthalmologe 109:165–170
doi: 10.1007/s00347-011-2511-x
pubmed: 22350551
Han H, Gao Y, Chai M, Zhang X, Liu S, Huang Y, Jin Q, Grzybowski A, Ji J, Yao K (2020) Biofilm microenvironment activated supramolecular nanoparticles for enhanced photodynamic therapy of bacterial keratitis. J Control Rel 327:676–687
doi: 10.1016/j.jconrel.2020.09.014
Bai Y, Hu Y, Gao Y, Wei X, Li J, Zhang Y, Wu Z, Zhang X (2021) Oxygen self-supplying nanotherapeutic for mitigation of tissue hypoxia and enhanced photodynamic therapy of bacterial keratitis. ACS Appl Mater Interfaces 13(29):33790–33801
doi: 10.1021/acsami.1c04996
pubmed: 34254513
Su G, Wei Z, Wang L, Shen J, Baudouin C, Labbé A, Liang Q (2020) Evaluation of toluidine blue-mediated photodynamic therapy for experimental bacterial keratitis in rabbits. Transl Vision Sci Technol 9(3):13
doi: 10.1167/tvst.9.3.13
Arboleda A, Miller D, Cabot F, Taneja M, Aguilar MC, Alawa K, Amescua G, Yoo SH, Parel JM (2014) Assessment of rose bengal versus riboflavin photodynamic therapy for inhibition of fungal keratitis isolates. Amer J Ophthalmol 158(1):64–70
doi: 10.1016/j.ajo.2014.04.007
pubmed: 24792103
Shih MH, Huang FC (2011) Effects of photodynamic therapy on rapidly growing nontuberculous mycobacteria keratitis. Invest Ophthalmol Vis Sci 52(1):223–229
doi: 10.1167/iovs.10-5593
pubmed: 20811055
Aqeel Y, Siddiqui R, Anwar A, Shah MR, Khoja S, Khan NA (2015) Photochemotherapeutic strategy against Acanthamoeba infections. Antimicrob Agents Chemother 59(6):3031–3041
doi: 10.1128/AAC.05126-14
pubmed: 25753633
pmcid: 4432153
Imran M, Muazzam AG, Habib A, Matin A (2016) Synthesis, characterization and amoebicidal potential of locally synthesized TiO
doi: 10.1016/j.jphotobiol.2016.03.014
Gomart G, Denis J, Bourcier T, Dory A, Abou-Bacar A, Candolfi E, Sauer A (2018) In vitro amoebicidal activity of titanium dioxide/UV-A combination against Acanthamoeba. Invest Ophthalmol Vis Sci 59(11):4567–4571
doi: 10.1167/iovs.18-25003
pubmed: 30242357
Dwia Pertiwi Y, Chikama T, Sueoka K, Ko JA, Kiuchi Y, Onodera M, Sakaguchi T (2021) Efficacy of photodynamic anti-microbial chemotherapy for Acanthamoeba keratitis in vivo. Lasers Surg Med 53(5):695–702
doi: 10.1002/lsm.23355
pubmed: 33615522
Pertiwi YD, Chikama T, Sueoka K, Ko JA, Kiuchi Y, Onodera M, Sakaguchi T (2019) Antimicrobial photodynamic therapy with the photosensitizer TONS504 eradicates Acanthamoeba. Photodiagnosis Photodyn Ther 28:166–171
doi: 10.1016/j.pdpdt.2019.08.035
pubmed: 31499180
Atalay HT, Uysal BS, Sarzhanov F, Usluca S, Yeşilırmak N, Özmen MC, Erganiş S, Tefon AB, Dogruman-Al F, Bilgihan K (2020) Rose Bengal-mediated photodynamic antimicrobial treatment of Acanthamoeba keratitis. Curr Eye Res 45(10):1205–1210
doi: 10.1080/02713683.2020.1731830
pubmed: 32065854
Chen Z, Xuguang S, Zhiqun W, Ran L (2008) In vitro amoebacidal activity of photodynamic therapy on Acanthamoeba. Brit J Ophthalmol 92(9):1283–1286
doi: 10.1136/bjo.2007.134288
Mito T, Suzuki T, Kobayashi T, Zheng X, Hayashi Y, Shiraishi A, Ohashi Y (2012) Effect of photodynamic therapy with methylene blue on Acanthamoeba in vitro. Invest Ophthalmol Vis Sci 53(10):6305–6313
doi: 10.1167/iovs.12-9828
pubmed: 22918636
Korea Institute of Science and Technology: KR20220158663A (2022).
Peyman GA: US20220409362A1 (2022).
Hangzhou Dac Biotech Co Ltd: AU2022206809A1 (2022).
Aldeyra Therapeutics, Inc.: WO2023278816A1 (2023).
Wenzhou Medical University: CN114907573A (2022).
Eye and ENT Hospital of Fudan University: CN115054432A (2022).
Wenzhou Medical University: CN114942530A (2022).
Wenzhou Medical University: CN114588524A (2022).
Allysta Pharmaceuticals Inc.: US20220331393A1 (2022).
Desmond Christopher Adler, Jason Hill, David Usher, Mikhail Smirnov, Ahalya Viswanathan: US20220193439A1 (2021).
Avedro Inc.: US20220054858A1 (2021).
Ushio Denki KK: US20220062473A1 (2022).
Nisshang Santen Pharmaceutical Co., Ltd., Nisshang Phibotek Medical Equipment Co., Ltd.: TW202216153A (2022).
Korea Advanced Institute of Science and Technology KAIST: US20210393723A1 (2021).
University Of Miami: WO2021237131A1 (2021).
University Of Miami: WO2021202398A1 (2021).
Wenzhou Research Institute Of Chinese Academy Of Sciences, Wenzhou Institute Of Biomaterials And Engineering: CN113041348A (2021).
Qingdao University: CN112891535A (2021).
Qingdao University: CN112915204A (2021).
Peyman GA: US20210113375A1 (2021).
Universidade De São Paulo – Usp: BR102020025170A2 (2021).
Peyman GA: US20210093884A1 (2021).
Vision Engineering Italy Srl: WO2021009623A1 (2020).
The University of Massachusetts, The General Hospital Corporation: WO2020251933A1 (2020).
Harbin Normal University: CN111467490A (2020).
Korea Institute of Science and Technology: KR20210093608A (2022).
University of California, US Department of Veterans Affairs VA: JP2022503941A (2022)
California Institute Of Technology: WO2020061079A1 (2020)
Seoul Viosys Co., Ltd.: WO2019209063A1 (2019)
Aleyegn Technologies LLC: US20200000638A1 (2020)
Garg P, Das S, Roy A (2017) Collagen cross-linking for microbial keratitis. Middle East Afr J Ophthalmol 24(1):18
pubmed: 28546688
pmcid: 5433123